The Scandinavian study mostly included patients with small fiber neuropathies, whereas our study was designed to be more inclusive in its selection criteria, given the phenotypic variability and the lack of clear phenotypic description of TTR-FAP in North America. The gene discussed is TTR; the disease is neuropathy, small fiber.